AstraZenca Pharma India Ltd. | ASTRAZEN | NSE - Pharmaceuticals
Financial Summary Report of AstraZenca Pharma India Ltd.
ASTRAZEN
AstraZenca Pharma India Ltd.
Rs. 5189.70
19-Apr-2024
5 Yr Performance
1 Yr Performance
Valuation
Quarterly Revenue, Net Income and Adjusted Share Price
Peer Comparison
Glaxosmithkline Pharmaceuticals Ltd.